Targeting Mesothelin-Low Tumors with Protein-Drug Conjugates
In the relentless pursuit of more effective cancer treatments, one of the greatest challenges has been the development of targeted ...
In the relentless pursuit of more effective cancer treatments, one of the greatest challenges has been the development of targeted ...
The blood–brain barrier (BBB) has long stood as a formidable obstacle in the treatment of central nervous system (CNS) tumors, ...
In a groundbreaking development within the arena of oncology, new data emerging from the phase 2 TD-NICE clinical trial reveals ...
In the relentless battle against recurrent ovarian cancer, researchers are exploring innovative approaches beyond the traditional chemotherapy regimens that have ...
In a groundbreaking comparative study published in the 2025 issue of BMC Cancer, researchers from the Fourth Hospital of Hebei ...
NRG Oncology, a cornerstone institution within the National Cancer Institute’s (NCI) National Clinical Trials Network (NCTN), has recently announced significant ...
In a groundbreaking development for the treatment of small cell lung cancer (SCLC), researchers have identified a novel therapeutic strategy ...
In a groundbreaking study poised to shift the paradigm in gastric cancer therapeutics, researchers have unveiled a novel strategy to ...
In a groundbreaking study published recently in Nature Communications, researchers have unveiled a novel immunomodulatory strategy that promises to revolutionize ...
In a groundbreaking advancement at the intersection of oncology, immunology, and microbiology, researchers at the Korea Advanced Institute of Science ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine